High Dub3 Expression in Mouse ESCs Couples the G1/S Checkpoint to Pluripotency

Molecular Cell

Volumn 52, Issue 3, 2013, Pages 366-379

  vanderLaan, Siem ^a   Tsanov, Nikolay ^a   Crozet, Carole ^a   Maiorano, Domenico ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CDC25A PHOSPHATASE; DNA; DUB3 PROTEIN; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ESRRB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL SYNCHRONIZATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; EMBRYONIC STEM CELL; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE TARGETING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

EID: 84887195033     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.10.003     Document Type: Article

References (53)

1. Abbas T., Sivaprasad U., Terai K., Amador V., Pagano M., Dutta A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008, 22:2496-2506.
2. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 1998, 8:145-155.
3. Bahassi M., Yin M., Robbins S.B., Li Y.Q., Conrady D.G., Yuan Z., Kovall R.A., Herr A.B., Stambrook P.J. A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosis. Cell Div. 2011, 6:4.
4. Ballabeni A., Park I.H., Zhao R., Wang W., Lerou P.H., Daley G.Q., Kirschner M.W. Cell cycle adaptations of embryonic stem cells. Proc. Natl. Acad. Sci. USA 2011, 108:19252-19257.
5. Bendjennat M., Boulaire J., Jascur T., Brickner H., Barbier V., Sarasin A., Fotedar A., Fotedar R. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 2003, 114:599-610.
6. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995, 377:552-557.
7. Buckley S.M., Aranda-Orgilles B., Strikoudis A., Apostolou E., Loizou E., Moran-Crusio K., Farnsworth C.L., Koller A.A., Dasgupta R., Silva J.C., et al. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell Stem Cell 2012, 11:783-798.
8. Busino L., Donzelli M., Chiesa M., Guardavaccaro D., Ganoth D., Dorrello N.V., Hershko A., Pagano M., Draetta G.F. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 2003, 426:87-91.
9. Busino L., Chiesa M., Draetta G.F., Donzelli M. Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene 2004, 23:2050-2056.
10. Chen X., Chi Y., Bloecher A., Aebersold R., Clurman B.E., Roberts J.M. N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). Mol. Cell 2004, 16:839-847.
11. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
12. Chen T., Du J., Lu G. Cell growth arrest and apoptosis induced by Oct4 or Nanog knockdown in mouse embryonic stem cells: a possible role of Trp53. Mol. Biol. Rep. 2012, 39:1855-1861.
13. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
14. Coronado D., Godet M., Bourillot P.Y., Tapponnier Y., Bernat A., Petit M., Afanassieff M., Markossian S., Malashicheva A., Iacone R., et al. A short G1 phase is an intrinsic determinant of naïve embryonic stem cell pluripotency. Stem Cell Res. (Amst.) 2013, 10:118-131.
15. de la Vega M., Kelvin A.A., Dunican D.J., McFarlane C., Burrows J.F., Jaworski J., Stevenson N.J., Dib K., Rappoport J.Z., Scott C.J., et al. The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. Nat. Commun. 2011, 2:259.
16. Deblois G., Hall J.A., Perry M.C., Laganière J., Ghahremani M., Park M., Hallett M., Giguère V. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res. 2009, 69:6149-6157.
17. Donzelli M., Squatrito M., Ganoth D., Hershko A., Pagano M., Draetta G.F. Dual mode of degradation of Cdc25 A phosphatase. EMBO J. 2002, 21:4875-4884.
18. Dulic V., Kaufmann W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., Elledge S.J., Reed S.I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994, 76:1013-1023.
19. Falck J., Mailand N., Syljuåsen R.G., Bartek J., Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410:842-847.
20. Feng B., Jiang J., Kraus P., Ng J.H., Heng J.C., Chan Y.S., Yaw L.P., Zhang W., Loh Y.H., Han J., et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 2009, 11:197-203.
21. Festuccia N., Osorno R., Halbritter F., Karwacki-Neisius V., Navarro P., Colby D., Wong F., Yates A., Tomlinson S.R., Chambers I. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490.
22. Festuccia N., Osorno R., Wilson V., Chambers I. The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states. Curr. Opin. Genet. Dev. 2013, 23:504-511.
23. Fujita J., Crane A.M., Souza M.K., Dejosez M., Kyba M., Flavell R.A., Thomson J.A., Zwaka T.P. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2008, 2:595-601.
24. Gautier E.F., Picard M., Laurent C., Marty C., Villeval J.L., Demur C., Delhommeau F., Hexner E., Giraudier S., Bonnevialle N., et al. The cell cycle regulator CDC25A is a target for JAK2V617F oncogene. Blood 2012, 119:1190-1199.
25. Hong Y., Stambrook P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl. Acad. Sci. USA 2004, 101:14443-14448.
26. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., Schafer X., Lun Y., Lemischka I.R. Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 442:533-538.
27. Karnani N., Dutta A. The effect of the intra-S-phase checkpoint on origins of replication in human cells. Genes Dev. 2011, 25:621-633.
28. Koledova Z., Kafkova L.R., Krämer A., Divoky V. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells. Stem Cells 2010, 28:450-461.
29. Lee H., Zeng S.X., Lu H. UV Induces p21 rapid turnover independently of ubiquitin and Skp2. J.Biol. Chem. 2006, 281:26876-26883.
30. Mailand N., Falck J., Lukas C., Syljuâsen R.G., Welcker M., Bartek J., Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000, 288:1425-1429.
31. Malumbres M., Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 2001, 1:222-231.
32. Martello G., Sugimoto T., Diamanti E., Joshi A., Hannah R., Ohtsuka S., Göttgens B., Niwa H., Smith A. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012, 11:491-504.
33. Minella A.C., Loeb K.R., Knecht A., Welcker M., Varnum-Finney B.J., Bernstein I.D., Roberts J.M., Clurman B.E. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages invivo. Genes Dev. 2008, 22:1677-1689.
34. Neganova I., Zhang X., Atkinson S., Lako M. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009, 28:20-30.
35. Neganova I., Vilella F., Atkinson S.P., Lloret M., Passos J.F., von Zglinicki T., O'Connor J.E., Burks D., Jones R., Armstrong L., Lako M. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011, 29:651-659.
36. Peco E., Escude T., Agius E., Sabado V., Medevielle F., Ducommun B., Pituello F. The CDC25B phosphatase shortens the G2 phase of neural progenitors and promotes efficient neuron production. Development 2012, 139:1095-1104.
37. Percharde M., Lavial F., Ng J.H., Kumar V., Tomaz R.A., Martin N., Yeo J.C., Gil J., Prabhakar S., Ng H.H., et al. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 2012, 26:2286-2298.
38. Pereg Y., Liu B.Y., O'Rourke K.M., Sagolla M., Dey A., Komuves L., French D.M., Dixit V.M. Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat. Cell Biol. 2010, 12:400-406.
39. Prost S., Bellamy C.O., Clarke A.R., Wyllie A.H., Harrison D.J. p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett. 1998, 425:499-504.
40. Ramakrishna S., Suresh B., Lee E.J., Lee H.J., Ahn W.S., Baek K.H. Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. J.Biol. Chem. 2011, 286:10505-10514.
41. Sabapathy K., Klemm M., Jaenisch R., Wagner E.F. Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 1997, 16:6217-6229.
42. Savatier P., Lapillonne H., Jirmanova L., Vitelli L., Samarut J. Analysis of the cell cycle in mouse embryonic stem cells. Methods Mol. Biol. 2002, 185:27-33.
43. Sexl V., Diehl J.A., Sherr C.J., Ashmun R., Beach D., Roussel M.F. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene 1999, 18:573-582.
44. Solozobova V., Rolletschek A., Blattner C. Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol. 2009, 10:46.
45. Stead E., White J., Faast R., Conn S., Goldstone S., Rathjen J., Dhingra U., Rathjen P., Walker D., Dalton S. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 2002, 21:8320-8333.
46. Thomson M., Liu S.J., Zou L.N., Smith Z., Meissner A., Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011, 145:875-889.
47. van den Berg D.L., Zhang W., Yates A., Engelen E., Takacs K., Bezstarosti K., Demmers J., Chambers I., Poot R.A. Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol. Cell. Biol. 2008, 28:5986-5995.
48. Walker E., Ohishi M., Davey R.E., Zhang W., Cassar P.A., Tanaka T.S., Der S.D., Morris Q., Hughes T.R., Zandstra P.W., Stanford W.L. Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment. Cell Stem Cell 2007, 1:71-86.
49. White J., Stead E., Faast R., Conn S., Cartwright P., Dalton S. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol. Biol. Cell 2005, 16:2018-2027.
50. Ying Q.L., Stavridis M., Griffiths D., Li M., Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 2003, 21:183-186.
51. Yu D.D., Forman B.M. Identification of an agonist ligand for estrogen-related receptors ERRbeta/gamma. Bioorg. Med. Chem. Lett. 2005, 15:1311-1313.
52. Zhang X., Zhang J., Wang T., Esteban M.A., Pei D. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J.Biol. Chem. 2008, 283:35825-35833.
53. Zhang X., Neganova I., Przyborski S., Yang C., Cooke M., Atkinson S.P., Anyfantis G., Fenyk S., Keith W.N., Hoare S.F., et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J.Cell Biol. 2009, 184:67-82.